UTHR

#531
United Therapeutics Corporation - Common Stock
557.7 5 USD
-0.77%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
556.00
563.04
Range Annuel
272.17
609.35
Changement quotidien
-0.77%
Changement Mensuel
-2.91%
Evolution sur 6 mois
+15.08%
Changement Annuel
+74.20%
Clôture Précédente
562.0 9
Open
562.7 4
Low
556.0 0
High
563.0 4
Volume
159
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 23.67 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
17.49
ratio cours/chiffre d'affaires
7.33

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Nouvelles